Your BMI says you're fine. Your waistline might disagree.

You've probably had your BMI checked at a doctor's visit. It's quick, it's simple, and it's been the standard measure of body composition for decades. The problem: it can miss real cardiovascular risk sitting right under your nose—literally at your waist.

What BMI actually measures (and what it doesn't)

BMI is a ratio of weight to height. If you're 5'10" and weigh 200 pounds, your BMI is 28.7. That calculation tells you nothing about where your weight lives. Someone at that same height and weight might carry most of it as muscle (from years of strength training). Someone else might carry it as fat concentrated around the abdomen. Their BMIs are identical. Their cardiovascular risk profiles? Completely different.

This distinction matters because where fat sits affects your health outcome. Fat stored around your organs—visceral fat, sitting deep in the abdomen—is metabolically active in ways that fat elsewhere isn't. It influences inflammation markers, lipid metabolism, insulin sensitivity, and blood pressure. Fat stored under the skin on your thighs or hips, by contrast, is relatively inert.

For decades, research has hinted at this difference. But the evidence was scattered. What we needed was a large, long-term study—one with enough people, enough time, and enough rigor to settle it. In August 2026, we got one.

The study: 259,388 people over 20 years

Researchers from Johns Hopkins and collaborating institutions pooled data from 15 different health cohorts. Their subjects: 259,388 adults without baseline heart disease, followed for a median of 20 years. Over that two decades, they measured something simple on every participant: waist circumference and waist-to-hip ratio (the ratio of your waist measurement to your hip measurement). They also tracked 9 major cardiovascular outcomes: heart attack, stroke, heart failure, atrial fibrillation, coronary heart disease, total cardiovascular disease, and mortality from each.

Then they asked: Do waist circumference and waist-to-hip ratio reclassify risk in a way BMI alone doesn't?

The finding: BMI hides risk in both directions

The answer was a definitive yes—and it went both ways.

Read that table carefully. Among people with a normal BMI, 5% had elevated waist circumference and 18% had a high waist-to-hip ratio. Those "normal weight" individuals—according to BMI—were carrying central adiposity. And it mattered: they had 15–50% greater risk for most cardiovascular outcomes compared to normal-weight peers without central adiposity.

On the flip side, among people classified as obese by BMI, 9% had low waist circumference and 45% had a low waist-to-hip ratio. These individuals—despite the "obese" label—carried their weight differently. Their risk profile was measurably better than their BMI suggested.

The exceptions were nuanced. In women (though not men), obesity combined with low waist-to-hip ratio still carried higher absolute risk than normal weight with low waist-to-hip ratio. But the difference was smaller than obesity with high waist-to-hip ratio—evidence that body composition distribution does modify the association.

The population impact: where central adiposity drives the most damage

Beyond individual risk, the researchers calculated something called population-attributable risk—the fraction of disease events in a population that could be tied to elevated waist circumference. The findings were striking:

• Heart failure: 49% of events among people with obesity were attributable to elevated waist circumference
• Atrial fibrillation: 46% of events were attributable to elevated waist circumference
• Coronary heart disease mortality: 36% of events were attributable to elevated waist circumference

Nearly half of heart-failure hospitalizations in people with obesity. Nearly half of new AFib diagnoses. These aren't marginal differences. They're disease-defining.

What this means for your risk assessment

The clinical bottom line, stated plainly by the study authors:

Measure waist circumference in addition to BMI.

It's simple, takes seconds, costs nothing, and captures information BMI misses. A tape measure is as actionable a tool in cardiovascular risk assessment as a weight scale—sometimes more so.

This doesn't mean BMI is useless. It's one data point. But it's an incomplete one. Two people at the same BMI can have dramatically different cardiovascular futures depending on where they carry their weight and whether they carry muscle or fat. Individual biology matters. The measurements we use should reflect that.